TABLE 8.
Matrix of pairwise comparisons on transfusion rates in intravenous (g) administration (shown as odds ratios and 95% confidence intervals)
| 1.0 g TXA IV | 2.0 g TXA IV | 5.0 g EACA IV | 10.0 g EACA IV | 14.0 g EACA IV | Placebo | |
|---|---|---|---|---|---|---|
| 1.0 g TXA IV | 1 | 0.19 (0, 4.49) | 0.17 (0, 34.84) | 0.58 (0.1, 2.64) | 0.04 (0, 4.1) | 5.01 (1.53, 17.07) |
| 2.0 g TXA IV | 5.29 (0.22, 294.29) | 1 | 0.99 (0.02, 61.65) | 3.02 (0.11, 165.14) | 0.26 (0, 5.89) | 26.44 (1.46, 1255.83) |
| 5.0 g EACA IV | 5.73 (0.03, 1598.32) | 1.01 (0.02, 62.88) | 1 | 3.28 (0.01, 849.81) | 0.25 (0, 45.47) | 28.86 (0.17, 7239.88) |
| 10.0 g EACA IV | 1.72 (0.38, 10.23) | 0.33 (0.01, 9.2) | 0.31 (0, 68.22) | 1 | 0.08 (0, 8.13) | 8.65 (2.5, 40.17) |
| 14.0 g EACA IV | 22.54 (0.24, 5155.59) | 3.89 (0.17, 202.23) | 4.05 (0.02, 1091.86) | 12.99 (0.12, 2905.01) | 1 | 114.61 (1.46, 23256.29) |
| Placebo | 0.2 (0.06, 0.65) | 0.04 (0, 0.69) | 0.03 (0, 6.04) | 0.12 (0.02, 0.4) | 0.01 (0, 0.68) | 1 |
Note: Bold results mean statistically significance.
Abbreviations: IA, intra‐articular; TXA, tranexamic acid; EACA, aminocaproic acid.